FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2121602104> ?p ?o ?g. }

• W2121602104 endingPage "123" @default.
• W2121602104 startingPage "116" @default.
• W2121602104 abstract "We designed a dose- and time-intensified high-dose sequential chemotherapy regimen for patients with relapsed and refractory Hodgkin lymphoma (HD).Eligibility criteria included age 18-65 years, histologically proven primary progressive (PD) or relapsed HD. Treatment consisted of two cycles DHAP (dexamethasone, high-dose cytarabine, cisplatinum); patients with chemosensitive disease received cyclophosphamide followed by peripheral blood stem cell harvest; methotrexate plus vincristine, etoposide and BEAM plus peripheral blood stem cell transplantation (PBSCT).A total of 102 patients (median age 34 years, range 18-64) were enrolled. The response rate was 80% (72% complete response, 8% partial response). With a median follow-up of 30 months (range 3-61 months), freedom from second failure (FF2F) and overall survival (OS) were 59% and 78% for all patients, respectively. FF2F and OS for patients with early relapse were 62% and 81%, for late relapse 65% and 81%; for PD 41% and 48%, and for multiple relapse 39% and 48%, respectively. In multivariate analysis response after DHAP (P <0.0001) and duration of first remission (PD and multiple relapse versus early and late relapse; P=0.0127) were prognostic factors for FF2F. Response after DHAP (P <0.0081), duration of first remission (P=0.0017) and anemia (P=0.019) were significant for OS.Based on the promising results of this study, a prospective randomized European intergroup study was started comparing this intensified regimen with two courses of DHAP followed by BEAM (HD-R2 protocol)." @default.
• W2121602104 created "2016-06-24" @default.
• W2121602104 creator A5000675096 @default.
• W2121602104 creator A5003056562 @default.
• W2121602104 creator A5009186146 @default.
• W2121602104 creator A5009836014 @default.
• W2121602104 creator A5018102467 @default.
• W2121602104 creator A5020056951 @default.
• W2121602104 creator A5049698111 @default.
• W2121602104 creator A5057387418 @default.
• W2121602104 creator A5057653899 @default.
• W2121602104 creator A5060652116 @default.
• W2121602104 creator A5063193304 @default.
• W2121602104 creator A5066679073 @default.
• W2121602104 creator A5080656211 @default.
• W2121602104 creator A5086465315 @default.
• W2121602104 date "2005-01-01" @default.
• W2121602104 modified "2023-10-03" @default.
• W2121602104 title "Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)" @default.
• W2121602104 cites W1538299886 @default.
• W2121602104 cites W1810011631 @default.
• W2121602104 cites W18139128 @default.
• W2121602104 cites W1824235478 @default.
• W2121602104 cites W1848336847 @default.
• W2121602104 cites W186782186 @default.
• W2121602104 cites W1901841160 @default.
• W2121602104 cites W1930936788 @default.
• W2121602104 cites W1982405153 @default.
• W2121602104 cites W2029747163 @default.
• W2121602104 cites W2049074090 @default.
• W2121602104 cites W2063600286 @default.
• W2121602104 cites W2122654415 @default.
• W2121602104 cites W2141082026 @default.
• W2121602104 cites W2151811168 @default.
• W2121602104 cites W2157717016 @default.
• W2121602104 cites W2158380419 @default.
• W2121602104 cites W2159746531 @default.
• W2121602104 cites W2161573782 @default.
• W2121602104 cites W2163991732 @default.
• W2121602104 cites W2269861991 @default.
• W2121602104 cites W2286687528 @default.
• W2121602104 cites W2304365550 @default.
• W2121602104 cites W2339293928 @default.
• W2121602104 cites W4249283733 @default.
• W2121602104 cites W4293241248 @default.
• W2121602104 cites W83964714 @default.
• W2121602104 doi "https://doi.org/10.1093/annonc/mdi003" @default.
• W2121602104 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15598948" @default.
• W2121602104 hasPublicationYear "2005" @default.
• W2121602104 type Work @default.
• W2121602104 sameAs 2121602104 @default.
• W2121602104 citedByCount "139" @default.
• W2121602104 countsByYear W21216021042012 @default.
• W2121602104 countsByYear W21216021042013 @default.
• W2121602104 countsByYear W21216021042014 @default.
• W2121602104 countsByYear W21216021042015 @default.
• W2121602104 countsByYear W21216021042016 @default.
• W2121602104 countsByYear W21216021042017 @default.
• W2121602104 countsByYear W21216021042018 @default.
• W2121602104 countsByYear W21216021042019 @default.
• W2121602104 countsByYear W21216021042020 @default.
• W2121602104 countsByYear W21216021042021 @default.
• W2121602104 countsByYear W21216021042022 @default.
• W2121602104 countsByYear W21216021042023 @default.
• W2121602104 crossrefType "journal-article" @default.
• W2121602104 hasAuthorship W2121602104A5000675096 @default.
• W2121602104 hasAuthorship W2121602104A5003056562 @default.
• W2121602104 hasAuthorship W2121602104A5009186146 @default.
• W2121602104 hasAuthorship W2121602104A5009836014 @default.
• W2121602104 hasAuthorship W2121602104A5018102467 @default.
• W2121602104 hasAuthorship W2121602104A5020056951 @default.
• W2121602104 hasAuthorship W2121602104A5049698111 @default.
• W2121602104 hasAuthorship W2121602104A5057387418 @default.
• W2121602104 hasAuthorship W2121602104A5057653899 @default.
• W2121602104 hasAuthorship W2121602104A5060652116 @default.
• W2121602104 hasAuthorship W2121602104A5063193304 @default.
• W2121602104 hasAuthorship W2121602104A5066679073 @default.
• W2121602104 hasAuthorship W2121602104A5080656211 @default.
• W2121602104 hasAuthorship W2121602104A5086465315 @default.
• W2121602104 hasBestOaLocation W21216021041 @default.
• W2121602104 hasConcept C126322002 @default.
• W2121602104 hasConcept C141071460 @default.
• W2121602104 hasConcept C181199279 @default.
• W2121602104 hasConcept C185592680 @default.
• W2121602104 hasConcept C2776694085 @default.
• W2121602104 hasConcept C2776755627 @default.
• W2121602104 hasConcept C2778041864 @default.
• W2121602104 hasConcept C2778336483 @default.
• W2121602104 hasConcept C2778822529 @default.
• W2121602104 hasConcept C2779050716 @default.
• W2121602104 hasConcept C2779429289 @default.
• W2121602104 hasConcept C2779617269 @default.
• W2121602104 hasConcept C2781413609 @default.
• W2121602104 hasConcept C55493867 @default.
• W2121602104 hasConcept C71924100 @default.
• W2121602104 hasConcept C90924648 @default.
• W2121602104 hasConceptScore W2121602104C126322002 @default.
• W2121602104 hasConceptScore W2121602104C141071460 @default.

• next